SCHEMBL8346290

SCHEMBL8346290

CC(C)(C)OC(=O)N(c1ccc(N2CCOCC2)cc1)c1ncnc(Cl)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.39
MAPT P10636 7/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MT-CO2 P00403 1/20 0.37
LMNA P02545 4/20 0.37
ALDH1A1 P00352 3/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
MITF O75030 1/20 0.37
TP53 P04637 1/20 0.37
XBP1 P17861 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
UBE2N P61088 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TLR9 Q9NR96 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.35
LCK P06239 3/20 0.35
AKR1C3 P42330 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8342236 0.78 GPX4 (0.39) MAPTMT-CO2ALDH1A1RAB9ANPC1
SCHEMBL278961 0.75 SYK (0.39) MAPTL3MBTL1MT-CO2LMNAALDH1A1
SCHEMBL8344153 0.74 MT-CO2 (0.36) MAPTMT-CO2ALDH1A1NPC1NPSR1
SCHEMBL1476113 0.72 GPR119 (0.36) GPR119MAPTMT-CO2LMNAALDH1A1
SCHEMBL17537442 0.71 LCK (0.41) MAPTMT-CO2LCK
SCHEMBL29023026 0.71 GPR119 (0.47) GPR119MAPTLMNAALDH1A1RAB9A
SCHEMBL9960220 0.70 GPR119 (0.44) GPR119MAPTLMNAALDH1A1RAB9A
SCHEMBL1674179 0.69 MAPKAPK5 (0.39) GPR119IDH1
SCHEMBL3994283 0.69 LMNA (0.41) LMNAALDH1A1HTTNPSR1TSHR
SCHEMBL31086578 0.67 MEN1 (0.40) MAPTL3MBTL1MT-CO2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256108-B1 SUBSTITUTED TRIAZINE KINASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2016-03-23 EP disclosed
EP-1546121-B1 SUBSTITUTED TRIAZINE KINASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-29 EP disclosed
EP-2256108-A1 Substituted triazine kinase inhibitors Janssen Pharmaceutica NV (BE) 2010-12-01 EP disclosed
US-7205298-B2 Substituted triazine kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-17 US disclosed
US-7205298-B2 Substituted triazine kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-17 US disclosed
WO-2004009562-A1 SUBSTITUTED TRIAZINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, NV (BE) 2004-01-29 WO disclosed